AstraZeneca has re-upped its UNICEF-partnered Young Health Programme (YHP), committing to a new five-year phase that will ...
Sign-ups for Medicare’s GLP-1 coverage plan keep expanding, and Eli Lilly is dominating the market with 70% share, the company’s CEO David Ricks said. | Sign-ups for Medicare’s GLP-1 coverage plan ...
Novo may be willing to transition some of its shares to the New York Stock Exchange in an effort to woo U.S. investors. | The Ozempic and Wegovy maker's CEO said he's open to a direct listing of ...
Despite hitting a speed bump over the summer, automated cell therapy manufacturing specialist Cellares has continued to sign new partners at a steady pace, now inking a second agreement with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results